Ticker Details
Gyre Therapeutics, Inc.
IPO Date:	August 21, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$715.76M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.39%
Avg Daily Range (30 D):	$0.16 | 2.57%
Avg Daily Range (90 D):	$0.19 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	262
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	124
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$2.04M
Avg Institutional Trade (90 D):	$2.04M
Avg Institutional Trade Volume:	.45M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.81M
Avg Closing Trade (30 D):	$3.54M
Avg Closing Trade (90 D):	$3.54M
Avg Closing Volume:	567.41K

News

May 4, 2026 @ 12:47 PM Gyre Therapeutics Completes Acquisition of Cullgen... Source: Globe Newswire

Mar 12, 2026 @ 10:00 AM Gyre Therapeutics Reports Fourth Quarter and Full ... Source: Na

Nov 7, 2025 @ 11:00 AM Gyre Therapeutics Reports Third Quarter 2025 and Y... Source: Gyre Therapeutics

Oct 14, 2025 @ 11:00 AM Gyre Therapeutics to Present Results from Positive... Source: Prof. Lungen Lu, M.D.

Aug 22, 2025 @ 11:00 AM Gyre Therapeutics Announces the Appointment of Dan... Source: Gyre Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.1	$-.02	$.06
Diluted EPS	$-.1	$-.02	$.02
Revenue	$22.52M	$37.2M	$116.59M
Gross Profit	$21.29M	$35.45M	$111.17M
Net Income / Loss	$-9.86M	$-1.37M	$9.88M
Operating Income / Loss	$-9.36M	$.12M	$11.49M
Cost of Revenue	$1.23M	$1.74M	$5.42M
Net Cash Flow	$.15M	$-3.46M	$24.91M
PE Ratio

Splits
Jan 13, 2023	2:1
Feb 13, 2017	1:15
Aug 21, 2015	1:7